Hydroxychloroquin

Phase 3Small molecule

RRadboud University Medical Center

Hydroxychloroquin is one of 3 small molecule programs targeting Child. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ChildCompleted

Lyme Borreliosis, Nervous SystemNot yet recruiting

ChildPreclinical

Completed

Lyme Borreliosis, Nervous SystemPhase 3

Not yet recruiting

Competition

Competitive Landscape

2 competitors in Child

#DrugCompanyPhaseTrials

Rayos

RRoxane Laboratories

Phase 2

1 2

Hydroxychloroquin

RRadboud University Medical Center

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

ApprovedNot yet recruiting

Lyme Borreliosis, Nervous System

NCT07230028

Clinical

Trials by Indication[1]

Child1 trial

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Completed·—·N/A·NCT03822780·25 enrolled

Lyme Borreliosis, Nervous System1 trial

A Monocenter, Randomized, Double Blind Pilot Study Comparing Doxycycline in Combination With Hydroxychloroquine Treatment Versus Doxycycline Monotherapy in Patients With Long-Term Complaints Attributed to Lyme Borreliosis.

Not yet recruiting·RRadboud University Medical Center·Approved·NCT07230028·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Hydroxychloroquin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hydroxychloroquin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hydroxychloroquin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Radboud University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: RRadboud University Medical Center

Hydroxychloroquin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Child1 trial

Lyme Borreliosis, Nervous System1 trial

References

Drug Info

Quick Facts

Related News